5 Hospitality lessons learned in 2017

2017 was a year defined by its challenges and crises. In these pivotal moments, the most important lessons are often learned. Here are 5 of those lessons in the hospitality and tourism industries. 1. Develop a communication plan ahead of time. When a crisis hits, knowing who needs to be in the loop and which emergency services are needed is essential. In an emergency, miscommunication can be costly. 2. Marketing can supplement product development, but can never replace it. The glossiest, most trendy marketing will fall flat without a completed product ready to go. 3. A reputation is slowly built and rapidly lost. Be open to criticism, not defensive. In crises especially, maintaining a sterling reputation is difficult and well worth the effort. 4. Keep in mind that international tourism hinges on security. In places notorious for their lack of security, tourism will always suffer. Be aware of this relationship and adjust accordingly. 5. Smile and enjoy the work. Customer service is far easier and more effective when done with genuine pleasure. Aim to please because it makes you feel good, not just for the bottom line. Customers will notice. As the hospitality and tourism industries enter 2018, it’s important not to forget these valuable lessons and others like them. When competition is tight, one slip-up can be costly.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More